Reproductive Health

2023-02-21T10:39:14-05:00July 1st, 2022|

Reproductive Health PH, Pregnancy and Contraception Pulmonary hypertension (PH) patients should avoid becoming pregnant because of the dangerous risks involved. Medications used to treat pulmonary arterial hypertension, such as ambrisentan, bosentan, macitentan and riociquat, are toxic to fetuses. Discontinuing the medication puts the mother at risk of worsening PH. Some blood thinners increase the

PH Co-Pay Assistance Fund Open at PAN Foundation

2020-12-21T14:29:06-05:00January 2nd, 2019|

As of 1/2/2019, Medicare recipients with pulmonary hypertension can apply for a co-pay assistance grant up to $5,300 from the PAN Foundation. Phone lines will likely be crowded, so online applications are encourage. Apply online at https://www.panapply.org/ or call 1-866-316-7263 For a general list of co-pay assistance resources developed by the Pulmonary Hypertension Association, visit